Polaris Genomics
Polaris Genomics: Pioneering precision medicine for improved behavioral health outcomes.
Founded
2017Polaris Genomics: Pioneering precision medicine for improved behavioral health outcomes.
Founded with a mission to reduce suicide, stigma, and suffering in silence, Polaris Genomics operates at the intersection of precision medicine and behavioral health. The company focuses on decoding the biological fingerprints of mental health conditions using genomics and AI. Their platform aims to bring clarity and objectivity to the assessment, diagnosis, and treatment of neuropsychiatric conditions, offering personalized, precision mental health care solutions.
Polaris Genomics has garnered attention for its innovative approach to mental health care, leveraging advanced genomic technologies. The company has attracted notable investors and partners in the biotech and healthcare sectors. Key achievements include the development of cutting-edge genomic tools that have the potential to revolutionize the understanding and treatment of PTSD and other mental health disorders. Through their pioneering work, Polaris Genomics is making a significant impact on the field of behavioral health, aiming to improve outcomes for individuals worldwide.
Companies similar to Polaris Genomics include Genomind, General Genomics, Unite Genomics and Genome Medical.
Polaris Genomics was founded in 2017.
Polaris Genomics' headquarters is located in Gaithersburg, MD, US.
Polaris Genomics' most recent funding round was for $1M (USD) in December 2023.
As of Dec 11, 2023, Polaris Genomics has disclosed funding of $4.7M (USD). Undisclosed round amounts are excluded.
Polaris Genomics has 35 employees as of Feb 4, 2024.
Genome Medical
genomemedical.com
